TY  - JOUR 
AU  - Reviejo Díaz, María
AU  - Soto, Meraris
AU  - Lozano, Elisa
AU  - Asensio Martín, Maitane
AU  - Martínez Augustín, Olga
AU  - Sánchez de Medina, Fermín
AU  - García Marín, José Juan
PY  - 2021
SN  - 0006-2952
UR  - http://hdl.handle.net/10366/159503
AB  - [EN] A shared characteristic of many tumors is the lack of response to anticancer drugs. Multiple mechanisms of
pharmacoresistance (MPRs) are involved in permitting cancer cells to overcome the effect of these agents.
Pharmacoresistance can be...
LA  - eng
PB  - Elsevier
KW  - Alternative splicing
KW  - Chemoresistance
KW  - Chemotherapy
KW  - Pharmacoresistance
KW  - Tumor
KW  - Spliceosome
KW  - Pharmacology
KW  - Medical Oncology
TI  - Impact of alternative splicing on mechanisms of resistance to anticancer drugs
DO  - 10.1016/j.bcp.2021.114810
T2  - Biochemical Pharmacology
VL  - 193
M2  - 114810
ER  -